Saturday November 21, 2009 12:20 AM ET
SmartMoney
Published December 1, 2008 9:14 AM  |  A A A
Breaking News by Dow Jones Newswires (Author Archive)

J&J Pays Up for Breast Implant Maker Mentor

NEW YORK (Dow Jones) -- Johnson & Johnson (JNJ) has agreed to acquire breast-implant maker Mentor Corp. (MNT) for $1.07 billion in a deal that could also give Allergan Inc. (AGN) a big rival in another cosmetic-surgery area -- Botox.

J&J is paying $31 for each Mentor share, a 92% premium to Friday's closing price. The stock traded above $31 as recently as June.

While most of Mentor's sales are from breast implants -- the company focuses on reconstruction for cancer patients, Mentor is awaiting word from the Food and Drug Administration for face fillers, the market for wrinkle treatment now dominiated by Botox.

Mentor, which will become part of J&J's Ethicon surgical-products business, is expected to cut J&J's 2009 earnings by about 3 cents to 5 cents a share. Analysts were expecting $4.67.

The deal, set to close in the first quarter, comes a week after JNJ said it agreed to buy Omrix Biopharmaceuticals Inc. (OMRI) for about $438 million, giving J&J full access to products which control bleeding during surgery.

-- Mike Barris, Dow Jones Newswires


Follow SmartMoney on Facebook, Twitter & More: Facebook Twitter
Bookmark and Share RSS
Advertisements

Related Quotes

JNJ 62.31 Up 0.37 0.60%